@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311095955 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-09"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL2311095955" ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "50" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "6.626 min" ;
            mbo:solvent " ",
                "%",
                ",",
                ".",
                "0",
                "1",
                ":",
                "A",
                "B",
                "F",
                "W",
                "a",
                "c",
                "d",
                "e",
                "i",
                "l",
                "m",
                "n",
                "o",
                "r",
                "t" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "threo-Dihydrobupropion" ;
            mbo:ch_compound_class "Pharmaceutical; Metabolite" ;
            mbo:ch_exact_mass 2.411233e+02 ;
            rdfs:seeAlso cas:92264-82-9 ;
            schema:inChI "InChI=1S/C13H20ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,12,15-16H,1-4H3" ;
            schema:inChIKey inchikey:NDPTTXIBLSWNSF-UHFFFAOYSA-N ;
            schema:molecularFormula "C13H20ClNO" ;
            schema:name "threo-Dihydrobupropion" ;
            schema:smiles "CC(C(c1cccc(c1)Cl)O)NC(C)(C)C" ] ;
    mbo:has_peak [ mbo:intensity 1.8e+00 ;
            mbo:mz 4.20417e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 7.7e+00 ;
            mbo:mz 1.25014e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 52 ],
        [ mbo:intensity 1.34e+01 ;
            mbo:mz 1.3208e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 91 ],
        [ mbo:intensity 1.39e+01 ;
            mbo:mz 1.330877e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 94 ],
        [ mbo:intensity 2.5e+00 ;
            mbo:mz 1.380103e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 17 ],
        [ mbo:intensity 4.5e+00 ;
            mbo:mz 1.490136e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 31 ],
        [ mbo:intensity 1.33e+01 ;
            mbo:mz 1.510291e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 90 ],
        [ mbo:intensity 4.7e+00 ;
            mbo:mz 1.520244e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 32 ],
        [ mbo:intensity 1.34e+01 ;
            mbo:mz 1.530334e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 91 ],
        [ mbo:intensity 1.77e+01 ;
            mbo:mz 1.680558e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 120 ],
        [ mbo:intensity 4.5e+00 ;
            mbo:mz 5.60539e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 31 ],
        [ mbo:intensity 9.9e+00 ;
            mbo:mz 5.70748e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 67 ],
        [ mbo:intensity 3.3e+00 ;
            mbo:mz 8.90384e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 8e+00 ;
            mbo:mz 9.10543e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 54 ],
        [ mbo:intensity 1.386e+02 ;
            mbo:mz 1.150545e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 941 ],
        [ mbo:intensity 1.472e+02 ;
            mbo:mz 1.160623e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.51e+01 ;
            mbo:mz 1.170568e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 102 ],
        [ mbo:intensity 1.03e+01 ;
            mbo:mz 1.180649e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 70 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 2.421306e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-014i-0900000000-e4b010f15a50c8de0e79" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "threo-Dihydrobupropion; LC-ESI-QTOF; MS2; 50 V" .

